skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 16.11d (Release date: 2016-11-28)
SearchBox Top
SearchBox Bottom
Adefovir Dipivoxil (Code C28811)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Adefovir Dipivoxil

Definition: A dipivoxil formulation of adefovir, a nucleoside reverse transcriptase inhibitor analog of adenosine with activity against hepatitis B virus (HBV), herpes virus, and human immunodeficiency virus (HIV).

Label: Adefovir Dipivoxil

NCI Thesaurus Code: C28811 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0540694  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
ADEFOVIR DIPIVOXIL
Adefovir Dipivoxil
GS-0840
Hepsera

External Source Codes: 
CAS Registry Number 142340-99-6 (see NLM ChemIDplus info)
FDA UNII Code U6Q8Z01514
PDQ Closed Trial Search ID 543979
PDQ Open Trial Search ID 543979 (check for NCI PDQ open clinical trial info)
UMLS CUI C0540694

Other Properties:
Name Value (qualifiers indented underneath)
Accepted_Therapeutic_Use_For Chronic Hepatitis B
Chemical_Formula C20H32N5O8P
code C28811
Contributing_Source FDA
Legacy_Concept_Name Adefovir
Semantic_Type Nucleic Acid, Nucleoside, or Nucleotide
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  

URL: https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28811

Mainbox Bottom